RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition is a research paper published in Science Advances (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA008748
Wellcome Trust
Grant: 110216
Mechanisms of Environmentally Stimulated Copy Number Variation.
Biotechnology and Biological Sciences Research Council
Grant: BBS/E/B/000C0423
Epigenetic responses to dietary change across organismal lifespan
Biotechnology and Biological Sciences Research Council
Grant: BBS/E/B/000C0424
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
FWCI
5.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Additional file 1 of Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor